CRO Popsi Cube has become an active member of Medicen Paris Region, a network of firms, research centres, universities, hospitals and economic development parks hosting biotechnology companies in the French capital.
A new firm joined the contract research sector this week with the launch of Neox Europe, an organisation combining a number of CROs operating across the continent that has global ambitions.
PRA has relocated its Poland-based early development services and product registration teams into a larger shared office after achieving “solid increases in the placement of clinical studies”.
Univar is now exclusively distributing Dow's Carbowax Sentry PEGs in Europe and the range is proving popular at CPhI 2010 with manufacturers facing restricted supply from other sources.
Penn Pharma and Xcelience have formed an Xcelodose-focused joint venture to meet client demand in Europe and Asia for powder-in-capsule (PIC) services.
Malgorzata Szerszeniewska, CEO of Central and Eastern Europe’s (CEE) “newest” CRO EastHorn, says maintaining ethical standards is crucial to sustaining the rapid patient recruitment rates that characterise the region.
Synexus has agreed to acquire Clinpharm, giving it access to 10 clinical trial sites in Germany, Austria and Ukraine and increasing its patient population reach in Europe by 100 per cent.
Cobra Biomanufacturing’s new Adenovirus manufacturing and process services contract is further evidence of the health of EU biologicals market, according to business development manager Philip Ridley-Smith.
Indian CRO Siro Clinpharm has set its sights on the European research market, signing a deal with UK based CambReg that it hopes will offer customers a path through the region’s complex regulations.
Synteract will open an office in Prague in the Czech Republic, joining the growing number of CROs to offer sponsors access to treatment naive populations in Central and Eastern Europe (CEE).
LGC Standards is increasing its presence in Asia through the opening of its first office in China, which will provide laboratory quality management services to the local market.
PPD has reached an agreement to buy AbCRO, which it hopes will strengthen its position in the thriving Central and Eastern European (CEE) clinical trials scene.
A new report suggests the large numbers of fake drugs produced in China could drive CMO customers away and see Central and Eastern Europe (CEE) emerge as a contract manufacturing hotbed.
Liverpool, UK-based biologics specialist Eden Biodesign has won three new manufacturing contracts - worth a total of £3m (€3.5m) – from clients in Europe and Asia.
RCP Therapeutics, a developer of regenerative medicine, hopes that its new HQ in the UK will benefit from the country’s status as a financial centre and proximity to cost effective trial sites in Eastern Europe.
Despite all the hype over clinical trial offshoring, the US still
dwarfs the scene, with emerging countries as yet only a blip on the
radar, a unique new study reveals.
A Polish and a Czech firm have merged together in a bid to
strengthen their position in the Central and Eastern Europe's
(CEE's) budding clinical research scene.
Copapharm Europe, the pan-European alliance of pharmaceutical
packagers, has significantly raised its game in the Spanish market
with a new member, Artes Graficas Nekar.
Ranbaxy has been granted an EU manufacturing and import license for
its Romania-based Terapia Ranbaxy subsidiary, and says it will make
the company a strategic regional hub for its operations in Europe.
Movianto has more than doubled its pharmaceutical storage capacity
at two of its European sites with the construction of two new
warehouses, in answer to increased demand.
European healthcare organisations are being driven to outsource
more and more IT operations due to escalating financial burdens,
increasing complexity of IT systems, and new government
initiatives.
European life sciences received an unexpected boost as the European
Science Foundation launched an initiative to help promote and
coordinate interaction among European life sciences researchers and
funders.
Laboratory service provider, LabConnect has announced its
intentions to expand into Central and Eastern Europe by adding
Synevo Medicover Laboratory Services to its LabConnect network,
becoming the first US-based central laboratory...
The world's largest patient recruitment firm, Synexus Clinical
Research has bagged its first Hungarian company in a bid to exploit
the growing clinical trial opportunities in the emerging Eastern
European market.
While European producers of active pharmaceutical ingredients
(APIs) will see their share of the global market fall in the next
few years, Asian markets are growing at phenomenal rates, with
India set to supplant Italy as the second...
Asia is emerging as a hot spot for low-cost medical device
manufacturing as European drug companies pursue outsourcing options
or relocate production to cut costs. This increasing Asian
competition is alarming for European medical...
Baxa has announced it is to move to direct sales and marketing
operations in Europe, bringing to an end its existing business
strategy, which sold its products through exclusive distributors,
with support provided by Baxa from their...
Premier Research has continued its spate of acquisitions this year,
with the latest addition of clinical research organization (CRO)
Imform, which will aid the company's expansion plans into Eastern
Europe.
Sweden's Biotage, a specialist in microwave synthesis and
chromatography systems for drug development and production, has
taken some of its European distribution into its own hands through
the purchase of Separtis Holding.
Packaging company Crown Holdings is planning to sell its plastic
closures business for approximately $750 million to European
private equity firm PAI partners.
Viatris, a German pharmaceutical company specialising in inhaled
medicines and other specialty drugs, has accepted a €750 million
takeover offer from Swedish drugs group Meda.
A recent study designed to assess biopharmaceutical innovation in
the member states of the Organisation for Economic Cooperation and
Development has found that, in terms of innovation and
biotechnology industry development, Belgium...
Italy's fine chemicals industry organisation, Afaquim, is
organising a conference in September aimed at coordinating the
efforts of European active pharmaceutical ingredient (API)
suppliers in the face of increasing competition...
The Netherlands has set up a programme to boost its biotechnology
sector by helping small and medium-sized biopharma firms to develop
and manufacture products, writes Phil Taylor.
New statistics released today show that total US investments in
R&D made by the biotechnology and pharmaceutical industry
topped $38.8 billion (€29.3 billion) during 2004. This beats the
$34.5 billion total set in 2003 and demonstrates...
High rates of antibiotic resistance in South and East Europe are
higher than in northern Europe because the regions have high rates
of antibiotic use, according to a study published in this week's
issue of The Lancet.
The pharmaceutical excipients industry urgently needs a system of
European master files, already used by the active pharmaceutical
ingredient sector (API), to stimulate innovation in the sector and
bring Europe's regulatory stance...
The market for low-cost generic drugs looks set to be buoyant for
the foreseeable future, both in Europe as a whole and in France,
according to Hubert Olivier, president of the French subsidiary of
the leading German generics group...